Newleaf Brands Announces its Move into State-of-the-art 7,500 sq. ft. Specialty Mycology R&D and Product Development Lab in Denver, Colorado Post published:June 2, 2020 Post category:Press Release
NewLeaf Brands Announces Name and Stock Ticker Symbol Change to Mydecine Innovations Group Inc. (CSE: MYCO) Post published:June 1, 2020 Post category:Press Release
NewLeaf Brands Provides an Update to its Shareholders on Recent Corporate Developments and Shares a Positive Outlook Post published:May 28, 2020 Post category:Press Release
Newleaf Announces Advisor Appointee, Dr. Aubrey Oliver, to Spearhead Jamaican-based Psilocybin Retreat Efforts Post published:May 26, 2020 Post category:Press Release
NewLeaf Brands Announces Oversubscription of Brokered Private Placement Led by Canaccord Genuity Post published:May 22, 2020 Post category:Press Release
NewLeaf Brands announces C$2.0 million brokered private placement led by Canaccord Genuity Post published:May 21, 2020 Post category:Press Release
NewLeaf Brands Agrees to Acquire Mindleap Health Inc., Mental Health Platform Post published:May 21, 2020 Post category:Press Release
NewLeaf Brands Wholly-owned Subsidiary, Mydecine Group is Working to Build an Ecosystem of Resources Targeted at Unlocking the Potential of Fungi for Human Wellness Post published:May 19, 2020 Post category:Press Release
NewLeaf Brands’ Subsidiary Mydecine Group Announces Build Out of Specialty Mycology Lab in Denver, Colorado Post published:May 19, 2020 Post category:Press Release
NewLeaf Brands Appoints Rob Roscow as Chief Science Officer Post published:May 12, 2020 Post category:Press Release